Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201Tl-chloride

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 8, 2010, Pages 1616-

  Rambaldi, Pier Francesco ^a   Cuccurullo, Vincenzo ^a   Cascini, Giuseppe Lucio ^b   Mansi, Luigi ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; PENTETREOTIDE IN 111; THALLIUM CHLORIDE TL 201;

BONE MARROW; HUMAN; LETTER; LYMPHOMA; SCINTIGRAPHY; THYMUS HYPERPLASIA; TREATMENT OUTCOME;

CHILD; CITRATES; GALLIUM; HUMANS; HYPERPLASIA; SOMATOSTATIN; THALLIUM; THYMUS GLAND;

EID: 77956186159     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1487-0     Document Type: Letter

References (3)

1. I Goethals P Hoste C De Vriendt P Smeets J Verlooy H Ham 2010 Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma Eur J Nucl Med Mol Imaging 37 3 462 467 10.1007/s00259-009-1280-0 19820931
2. L Mansi PF Rambaldi F Casale M Masone P Indolfi A Murano, et al. 1996 In-111 pentetreotide and Ga-67 citrate uptake in benign thymic hyperplasia after chemotherapy in children with lymphoma J Nucl Med 37 256P
3. Rambaldi PF, Cascini GL, Casale F, Murano A, Fallanca F, Indolfi P, et al. In111 OCT and TL201 scintigraphy in thymic rebound after chemotheraphy in children with lymphoma. Eur J Nucl Med 1998;25:OS-50P.